Capita Healthcare Decisions, in partnership with China’s National Health and Development Research Centre (CNHDRC) and the International Decision Support Initiative (iDSI), has successfully won funding from the UK Government to support healthcare development in China.
The Prosperity Fund, a cross-government initiative managed by the Foreign and Commonwealth Office (FCO), is a £1.3 billion fund to promote the economic reform and development needed for growth in eligible partner countries over the next five years. Funding is being received by a number of providers. In China the project has six objectives consistent with the Fund’s global goal of promoting reform and growth – including a focus on healthcare.
The strategic partnership between Capita, CNHDRC and the iDSI (which is led by the National Institute for Health and Clinical Excellence (NICE) International), will enable extensive skill sharing and strategic guidance, allowing Chinese healthcare to achieve benefits and improvements in a number of areas.
As part of this, Capita will use its 16 years of experience to guide Chinese healthcare organisations on the use of clinical content. As well as its widely used and accredited specialist clinical teletriage algorithms, and patient focused web based clinical algorithms, Capita’s internal clinical editorial team – supported by an extensive network of external experts – can create or update tailored clinical content to meet clients’ requirements.
Insight will also be given on the capability to make this content digitally dynamic using Capita’s Decision Management System (DMS) technology and Patient Relationship Management System, Salus, built on Microsoft Dynamics CRM.
This strategic relationship between three leading authorities in healthcare policy and healthcare technology, with particular strengths in emerging markets, will set the foundations for transformed healthcare delivery.
Dr Charles Young, chief medical officer at Capita Healthcare Decisions, said:
“Our relationship with iDSI and CNHDRC is extremely exciting, both strategically and in a practical way. Working closely with these partners enables us to functionalise high level strategic guidance, and so enable healthcare providers to directly improve health outcomes globally.”
For further details contact Market Director Gary Impett. email@example.com